Converge Bio
The Generative AI Lab for the Life Sciences
Converge Bio is a 11-50-employee Biotechnology Research company based in Tel Aviv-Yafo, Tel Aviv. Founded in 2024. Has raised $25M, most recently at the Series A stage. Its most recent round on file is dated Jan 13, 2026. Adamlead has 1 contact on file at Converge Bio.
Company details
Tech stack
Not on file.
People at Converge Bio
| Name | Title | |
|---|---|---|
Dov Gertz | — | d***@converge-bio.comVerified |
Companies similar to Converge Bio
Frequently asked questions
When did Converge Bio last raise funding?+
Converge Bio's most recent round on file is dated Jan 13, 2026, at the Series A stage. Total funding on file: $25M.
How many contacts does Adamlead have for Converge Bio?+
We have 1 contact on file for Converge Bio. Each email shows its verification status and a confidence score.
What industry is Converge Bio in?+
Converge Bio is categorized under Biotechnology Research on Adamlead, alongside 18 other companies in the segment.
Can I get verified emails for people at Converge Bio?+
Yes. Start a 7-day free trial and reveal any contact's email for one credit. Every address carries a confidence score, and revealing the same contact again is always free.
What companies are similar to Converge Bio?+
Other Biotechnology Research startups on Adamlead, closest first by funding stage, include 3Helix, Curve Biosciences, Until. See the list below for more.
Reveal verified contacts at Converge Bio
Converge Bio raised on Jan 13, 2026 — reach out while the budget is fresh. 7-day free trial, no card required.
Start free trial